| 1. Sawyer TK, Hruby VJ, Wilkes BC, Draelos MT, Hadley ME, Bergsneider M.. (1982) Comparative biological activities of highly potent active-site analogues of alpha-melanotropin., 25 (9): [PMID:6982339] [10.1021/jm00351a004] |
| 2. Cheung AW, Danho W, Swistok J, Qi L, Kurylko G, Rowan K, Yeon M, Franco L, Chu XJ, Chen L, Yagaloff K.. (2003) Structure-activity relationship of linear peptide Bu-His-DPhe-Arg-Trp-Gly-NH(2) at the human melanocortin-1 and -4 receptors: histidine substitution., 13 (1): [PMID:12467633] [10.1016/s0960-894x(02)00830-2] |
| 3. Han G, Haskell-Luevano C, Kendall L, Bonner G, Hadley ME, Cone RD, Hruby VJ.. (2004) De novo design, synthesis, and pharmacology of alpha-melanocyte stimulating hormone analogues derived from somatostatin by a hybrid approach., 47 (6): [PMID:14998337] [10.1021/jm030452x] |
| 4. Haskell-Luevano C, Nikiforovich G, Sharma SD, Yang YK, Dickinson C, Hruby VJ, Gantz I.. (1997) Biological and conformational examination of stereochemical modifications using the template melanotropin peptide, Ac-Nle-c[Asp-His-Phe-Arg-Trp-Ala-Lys]-NH2, on human melanocortin receptors., 40 (11): [PMID:9171884] [10.1021/jm960845e] |
| 5. Joseph CG, Bauzo RM, Xiang Z, Haskell-Luevano C.. (2003) Urea small molecule agonists on mouse melanocortin receptors., 13 (12): [PMID:12781199] [10.1016/s0960-894x(03)00318-4] |
| 6. Haskell-Luevano C, Hendrata S, North C, Sawyer TK, Hadley ME, Hruby VJ, Dickinson C, Gantz I.. (1997) Discovery of prototype peptidomimetic agonists at the human melanocortin receptors MC1R and MC4R., 40 (14): [PMID:9216831] [10.1021/jm960840h] |
| 7. Wilczynski A, Wang XS, Joseph CG, Xiang Z, Bauzo RM, Scott JW, Sorensen NB, Shaw AM, Millard WJ, Richards NG, Haskell-Luevano C.. (2004) Identification of putative agouti-related protein(87-132)-melanocortin-4 receptor interactions by homology molecular modeling and validation using chimeric peptide ligands., 47 (9): [PMID:15084118] [10.1021/jm0303608] |
| 8. Haskell-Luevano C, Holder JR, Monck EK, Bauzo RM.. (2001) Characterization of melanocortin NDP-MSH agonist peptide fragments at the mouse central and peripheral melanocortin receptors., 44 (13): [PMID:11405661] [10.1021/jm010061n] |
| 9. Cheung AW, Danho W, Swistok J, Qi L, Kurylko G, Franco L, Yagaloff K, Chen L.. (2002) Structure-activity relationship of linear peptide Bu-His-DPhe-Arg-Trp-Gly-NH(2) at the human melanocortin-1 and -4 receptors: arginine substitution., 12 (17): [PMID:12161144] [10.1016/s0960-894x(02)00459-6] |
| 10. Koikov LN, Ebetino FH, Solinsky MG, Cross-Doersen D, Knittel JJ.. (2003) Sub-nanomolar hMC1R agonists by end-capping of the melanocortin tetrapeptide His-D-Phe-Arg-Trp-NH(2)., 13 (16): [PMID:12873485] [10.1016/s0960-894x(03)00552-3] |
| 11. Haskell-Luevano C, Toth K, Boteju L, Job C, Castrucci AM, Hadley ME, Hruby VJ.. (1997) beta-Methylation of the Phe7 and Trp9 melanotropin side chain pharmacophores affects ligand-receptor interactions and prolonged biological activity., 40 (17): [PMID:9276019] [10.1021/jm970018t] |
| 12. Holder JR, Bauzo RM, Xiang Z, Haskell-Luevano C.. (2002) Structure-activity relationships of the melanocortin tetrapeptide Ac-His-DPhe-Arg-Trp-NH(2) at the mouse melanocortin receptors. 1. Modifications at the His position., 45 (13): [PMID:12061882] [10.1021/jm0104872] |
| 13. Holder JR, Bauzo RM, Xiang Z, Haskell-Luevano C.. (2002) Structure-activity relationships of the melanocortin tetrapeptide Ac-His-DPhe-Arg-Trp-NH(2) at the mouse melanocortin receptors: part 2 modifications at the Phe position., 45 (14): [PMID:12086493] [10.1021/jm010524p] |
| 14. Hruby VJ, Lu D, Sharma SD, Castrucci AL, Kesterson RA, al-Obeidi FA, Hadley ME, Cone RD.. (1995) Cyclic lactam alpha-melanotropin analogues of Ac-Nle4-cyclo[Asp5, D-Phe7,Lys10] alpha-melanocyte-stimulating hormone-(4-10)-NH2 with bulky aromatic amino acids at position 7 show high antagonist potency and selectivity at specific melanocortin receptors., 38 (18): [PMID:7658432] [10.1021/jm00018a005] |
| 15. Balse-Srinivasan P, Grieco P, Cai M, Trivedi D, Hruby VJ.. (2003) Structure-activity relationships of novel cyclic alpha-MSH/beta-MSH hybrid analogues that lead to potent and selective ligands for the human MC3R and human MC5R., 46 (17): [PMID:12904077] [10.1021/jm030111j] |
| 16. Terasaka T, Kinoshita T, Kuno M, Seki N, Tanaka K, Nakanishi I.. (2004) Structure-based design, synthesis, and structure-activity relationship studies of novel non-nucleoside adenosine deaminase inhibitors., 47 (15): [PMID:15239652] [10.1021/jm0306374] |
| 17. Hruby VJ.. (2003) Peptide science: exploring the use of chemical principles and interdisciplinary collaboration for understanding life processes., 46 (20): [PMID:13678399] [10.1021/jm0303103] |
| 18. Grieco P, Balse PM, Weinberg D, MacNeil T, Hruby VJ.. (2000) D-Amino acid scan of gamma-melanocyte-stimulating hormone: importance of Trp(8) on human MC3 receptor selectivity., 43 (26): [PMID:11150170] [10.1021/jm000211e] |
| 19. Holder JR, Xiang Z, Bauzo RM, Haskell-Luevano C.. (2002) Structure-activity relationships of the melanocortin tetrapeptide Ac-His-D-Phe-Arg-Trp-NH2 at the mouse melanocortin receptors. 4. Modifications at the Trp position., 45 (26): [PMID:12477357] [10.1021/jm020296e] |
| 20. Cai M, Mayorov AV, Cabello C, Stankova M, Trivedi D, Hruby VJ.. (2005) Novel 3D pharmacophore of alpha-MSH/gamma-MSH hybrids leads to selective human MC1R and MC3R analogues., 48 (6): [PMID:15771429] [10.1021/jm049579s] |
| 21. Wilczynski A, Wilson KR, Scott JW, Edison AS, Haskell-Luevano C.. (2005) Structure-activity relationships of the unique and potent agouti-related protein (AGRP)-melanocortin chimeric Tyr-c[beta-Asp-His-DPhe-Arg-Trp-Asn-Ala-Phe-Dpr]-Tyr-NH2 peptide template., 48 (8): [PMID:15828845] [10.1021/jm049010r] |
| 22. Todorovic A, Holder JR, Bauzo RM, Scott JW, Kavanagh R, Abdel-Malek Z, Haskell-Luevano C.. (2005) N-terminal fatty acylated His-dPhe-Arg-Trp-NH(2) tetrapeptides: influence of fatty acid chain length on potency and selectivity at the mouse melanocortin receptors and human melanocytes., 48 (9): [PMID:15857138] [10.1021/jm0490843] |
| 23. Hogan K, Peluso S, Gould S, Parsons I, Ryan D, Wu L, Visiers I.. (2006) Mapping the binding site of melanocortin 4 receptor agonists: a hydrophobic pocket formed by I3.28(125), I3.32(129), and I7.42(291) is critical for receptor activation., 49 (3): [PMID:16451057] [10.1021/jm050780s] |
| 24. Joseph CG, Wang XS, Scott JW, Bauzo RM, Xiang Z, Richards NG, Haskell-Luevano C.. (2004) Stereochemical studies of the monocyclic agouti-related protein (103-122) Arg-Phe-Phe residues: conversion of a melanocortin-4 receptor antagonist into an agonist and results in the discovery of a potent and selective melanocortin-1 agonist., 47 (27): [PMID:15615519] [10.1021/jm0492756] |
| 25. Hess S, Linde Y, Ovadia O, Safrai E, Shalev DE, Swed A, Halbfinger E, Lapidot T, Winkler I, Gabinet Y, Faier A, Yarden D, Xiang Z, Portillo FP, Haskell-Luevano C, Gilon C, Hoffman A.. (2008) Backbone cyclic peptidomimetic melanocortin-4 receptor agonist as a novel orally administrated drug lead for treating obesity., 51 (4): [PMID:18220330] [10.1021/jm701093y] |
| 26. Proneth B, Pogozheva ID, Portillo FP, Mosberg HI, Haskell-Luevano C.. (2008) Melanocortin tetrapeptide Ac-His-DPhe-Arg-Trp-NH2 modified at the para position of the benzyl side chain (DPhe): importance for mouse melanocortin-3 receptor agonist versus antagonist activity., 51 (18): [PMID:18800761] [10.1021/jm800291b] |
| 27. Ruwe AR, Koikov L, Abdel-Malek Z, Haskell-Luevano C, Dirain ML, Portillo F, Xiang Z, Wortman M, Knittel JJ.. (2009) Semi-rigid tripeptide agonists of melanocortin receptors., 19 (17): [PMID:19635667] [10.1016/j.bmcl.2009.07.025] |
| 28. Liu H, Altenbach RJ, Carr TL, Chandran P, Hsieh GC, Lewis LG, Manelli AM, Milicic I, Marsh KC, Miller TR, Strakhova MI, Vortherms TA, Wakefield BD, Wetter JM, Witte DG, Honore P, Esbenshade TA, Brioni JD, Cowart MD.. (2008) cis-4-(Piperazin-1-yl)-5,6,7a,8,9,10,11,11a-octahydrobenzofuro[2,3-h]quinazolin-2-amine (A-987306), a new histamine H4R antagonist that blocks pain responses against carrageenan-induced hyperalgesia., 51 (22): [PMID:18983139] [10.1021/jm8007618] |
| 29. Singh A, Wilczynski A, Holder JR, Witek RM, Dirain ML, Xiang Z, Edison AS, Haskell-Luevano C.. (2011) Incorporation of a bioactive reverse-turn heterocycle into a peptide template using solid-phase synthesis to probe melanocortin receptor selectivity and ligand conformations by 2D 1H NMR., 54 (5): [PMID:21306168] [10.1021/jm101425m] |
| 30. Barkey NM, Tafreshi NK, Josan JS, De Silva CR, Sill KN, Hruby VJ, Gillies RJ, Morse DL, Vagner J.. (2011) Development of melanoma-targeted polymer micelles by conjugation of a melanocortin 1 receptor (MC1R) specific ligand., 54 (23): [PMID:22011200] [10.1021/jm201226w] |
| 31. Conde-Frieboes K, Thøgersen H, Lau JF, Sensfuss U, Hansen TK, Christensen L, Spetzler J, Olsen HB, Nilsson C, Raun K, Dahl K, Hansen BS, Wulff BS.. (2012) Identification and in vivo and in vitro characterization of long acting and melanocortin 4 receptor (MC4-R) selective α-melanocyte-stimulating hormone (α-MSH) analogues., 55 (5): [PMID:22335602] [10.1021/jm201489a] |
| 32. USP Dictionary of USAN and International Names (2010 edition) and USAN registrations 2007-date, |
| 33. Singh A, Dirain M, Witek R, Rocca JR, Edison AS, Haskell-Luevano C.. (2013) Structure-activity relationships of peptides incorporating a bioactive reverse-turn heterocycle at the melanocortin receptors: identification of a 5800-fold mouse melanocortin-3 receptor (mMC3R) selective antagonist/partial agonist versus the mouse melanocortin-4 receptor (mMC4R)., 56 (7): [PMID:23432160] [10.1021/jm301253y] |
| 34. Brabez N, Saunders K, Nguyen KL, Jayasundera TB, Weber C, Lynch RM, Chassaing G, Lavielle S, Hruby VJ.. (2013) Multivalent Interactions: Synthesis and Evaluation of Melanotropin Multimers - Tools for Melanoma Targeting., 4 (1): [PMID:23524643] [10.1021/ml300312b] |
| 35. Veinberg G, Vorona M, Zvejniece L, Vilskersts R, Vavers E, Liepinsh E, Kazoka H, Belyakov S, Mishnev A, Kuznecovs J, Vikainis S, Orlova N, Lebedev A, Ponomaryov Y, Dambrova M.. (2013) Synthesis and biological evaluation of 2-(5-methyl-4-phenyl-2-oxopyrrolidin-1-yl)-acetamide stereoisomers as novel positive allosteric modulators of sigma-1 receptor., 21 (10): [PMID:23582449] [10.1016/j.bmc.2013.03.016] |
| 36. Cappelli A, Manini M, Valenti S, Castriconi F, Giuliani G, Anzini M, Brogi S, Butini S, Gemma S, Campiani G, Giorgi G, Mennuni L, Lanza M, Giordani A, Caselli G, Letari O, Makovec F.. (2013) Synthesis and structure-activity relationship studies in serotonin 5-HT(1A) receptor agonists based on fused pyrrolidone scaffolds., 63 [PMID:23466604] [10.1016/j.ejmech.2013.01.044] |
| 37. Haslach EM, Huang H, Dirain M, Debevec G, Geer P, Santos RG, Giulianotti MA, Pinilla C, Appel JR, Doering SR, Walters MA, Houghten RA, Haskell-Luevano C.. (2014) Identification of tetrapeptides from a mixture based positional scanning library that can restore nM full agonist function of the L106P, I69T, I102S, A219V, C271Y, and C271R human melanocortin-4 polymorphic receptors (hMC4Rs)., 57 (11): [PMID:24517312] [10.1021/jm500064t] |
| 38. Testa C, Scrima M, Grimaldi M, D'Ursi AM, Dirain ML, Lubin-Germain N, Singh A, Haskell-Luevano C, Chorev M, Rovero P, Papini AM.. (2014) 1,4-disubstituted-[1,2,3]triazolyl-containing analogues of MT-II: design, synthesis, conformational analysis, and biological activity., 57 (22): [PMID:25347033] [10.1021/jm501027w] |
| 39. Waszkielewicz AM, Gunia-Krzyżak A, Powroźnik B, Słoczyńska K, Pękala E, Walczak M, Bednarski M, Żesławska E, Nitek W, Marona H.. (2016) Design, physico-chemical properties and biological evaluation of some new N-[(phenoxy)alkyl]- and N-{2-[2-(phenoxy)ethoxy]ethyl}aminoalkanols as anticonvulsant agents., 24 (8): [PMID:26988801] [10.1016/j.bmc.2016.03.006] |
| 40. Lensing CJ, Freeman KT, Schnell SM, Adank DN, Speth RC, Haskell-Luevano C.. (2016) An in Vitro and in Vivo Investigation of Bivalent Ligands That Display Preferential Binding and Functional Activity for Different Melanocortin Receptor Homodimers., 59 (7): [PMID:26959173] [10.1021/acs.jmedchem.5b01894] |
| 41. WHO Anatomical Therapeutic Chemical Classification, |
| 42. Gunia-Krzyżak A, Żelaszczyk D, Rapacz A, Żesławska E, Waszkielewicz AM, Pańczyk K, Słoczyńska K, Pękala E, Nitek W, Filipek B, Marona H.. (2017) Structure-anticonvulsant activity studies in the group of (E)-N-cinnamoyl aminoalkanols derivatives monosubstituted in phenyl ring with 4-Cl, 4-CH3 or 2-CH3., 25 (2): [PMID:27876250] [10.1016/j.bmc.2016.11.014] |
| 43. Ericson MD, Freeman KT, Schnell SM, Haskell-Luevano C.. (2017) A Macrocyclic Agouti-Related Protein/[Nle4,DPhe7]α-Melanocyte Stimulating Hormone Chimeric Scaffold Produces Subnanomolar Melanocortin Receptor Ligands., 60 (2): [PMID:28045525] [10.1021/acs.jmedchem.6b01707] |
| 44. Palmer D, Gonçalves JPL, V Hansen L, Wu B, Hald H, Schoffelen S, Diness F, Le Quement ST, Nielsen TE, Meldal M.. (2017) Click-Chemistry-Mediated Synthesis of Selective Melanocortin Receptor 4 Agonists., 60 (21): [PMID:28972753] [10.1021/acs.jmedchem.7b00353] |
| 45. Ericson MD, Freeman KT, Schnell SM, Fleming KA, Haskell-Luevano C.. (2017) Structure-Activity Relationship Studies on a Macrocyclic Agouti-Related Protein (AGRP) Scaffold Reveal Agouti Signaling Protein (ASP) Residue Substitutions Maintain Melanocortin-4 Receptor Antagonist Potency and Result in Inverse Agonist Pharmacology at the Melanocortin-5 Receptor., 60 (19): [PMID:28813605] [10.1021/acs.jmedchem.7b00856] |
| 46. Ericson MD, Singh A, Tala SR, Haslach EM, Dirain MLS, Schaub JW, Flores V, Eick N, Lensing CJ, Freeman KT, Smeester BA, Adank DN, Wilber SL, Speth R, Haskell-Luevano C.. (2018) Human β-Defensin 1 and β-Defensin 3 (Mouse Ortholog mBD14) Function as Full Endogenous Agonists at Select Melanocortin Receptors., 61 (8): [PMID:29578343] [10.1021/acs.jmedchem.8b00251] |
| 47. Doering SR, Freeman KT, Schnell SM, Haslach EM, Dirain M, Debevec G, Geer P, Santos RG, Giulianotti MA, Pinilla C, Appel JR, Speth RC, Houghten RA, Haskell-Luevano C.. (2017) Discovery of Mixed Pharmacology Melanocortin-3 Agonists and Melanocortin-4 Receptor Tetrapeptide Antagonist Compounds (TACOs) Based on the Sequence Ac-Xaa1-Arg-(pI)DPhe-Xaa4-NH2., 60 (10): [PMID:28453292] [10.1021/acs.jmedchem.7b00301] |
| 48. Fleming KA, Freeman KT, Ericson MD, Haskell-Luevano C.. (2018) Synergistic Multiresidue Substitutions of a Macrocyclic c[Pro-Arg-Phe-Phe-Asn-Ala-Phe-dPro] Agouti-Related Protein (AGRP) Scaffold Yield Potent and >600-Fold MC4R versus MC3R Selective Melanocortin Receptor Antagonists., 61 (17): [PMID:30035543] [10.1021/acs.jmedchem.8b00684] |
| 49. Unpublished dataset, |
| 50. Winget MD, Ericson MD, Freeman KT, Haskell-Luevano C.. (2020) Single Nucleotide Polymorphisms in the Melanocortin His-Phe-Arg-Trp Sequences Decrease Tetrapeptide Potency and Efficacy., 11 (3): [PMID:32184956] [10.1021/acsmedchemlett.9b00198] |
| 51. Koerperich ZM, Ericson MD, Freeman KT, Speth RC, Pogozheva ID, Mosberg HI, Haskell-Luevano C.. (2020) Incorporation of Agouti-Related Protein (AgRP) Human Single Nucleotide Polymorphisms (SNPs) in the AgRP-Derived Macrocyclic Scaffold c[Pro-Arg-Phe-Phe-Asn-Ala-Phe-dPro] Decreases Melanocortin-4 Receptor Antagonist Potency and Results in the Discovery of Melanocortin-5 Receptor Antagonists., 63 (5): [PMID:31845801] [10.1021/acs.jmedchem.9b00860] |
| 52. Fleming KA, Freeman KT, Powers MD, Santos RG, Debevec G, Giulianotti MA, Houghten RA, Doering SR, Pinilla C, Haskell-Luevano C.. (2019) Discovery of Polypharmacological Melanocortin-3 and -4 Receptor Probes and Identification of a 100-Fold Selective nM MC3R Agonist versus a μM MC4R Partial Agonist., 62 (5): [PMID:30741545] [10.1021/acs.jmedchem.9b00053] |
| 53. Unpublished dataset, |
| 54. Ericson MD,Shaikh R,Larson CM,Freeman KT,Haskell-Luevano C. (2021) Multiresidue Tetrapeptide Substitutions Yield a 140-fold Selective Melanocortin-3 over Melanocortin-4 Receptor Agonist., 12 (1): [PMID:33488972] [10.1021/acsmedchemlett.0c00561] |
| 55. Yuan S,Yu B,Liu HM. (2020) New drug approvals for 2019: Synthesis and clinical applications., 205 [PMID:32911308] [10.1016/j.ejmech.2020.112667] |
| 56. Ericson MD,Freeman KT,Haskell-Luevano C. (2020) Peptoid NPhe in AGRP-Based c[Pro-Arg-Phe-Phe-Xxx-Ala-Phe-DPro] Scaffolds Maintain Mouse MC4R Antagonist Potency., 11 (10): [PMID:33062177] [10.1021/acsmedchemlett.9b00641] |
| 57. Ericson MD, Doering SR, Larson CM, Freeman KT, LaVoi TM, Donow HM, Santos RG, Cho RH, Koerperich ZM, Giulianotti MA, Pinilla C, Houghten RA, Haskell-Luevano C.. (2021) Functional Mixture-Based Positional Scan Identifies a Library of Antagonist Tetrapeptide Sequences (LAtTeS) with Nanomolar Potency for the Melanocortin-4 Receptor and Equipotent with the Endogenous AGRP(86-132) Antagonist., 64 (19.0): [PMID:34592820] [10.1021/acs.jmedchem.1c01417] |
| 58. Doering SR, Freeman K, Debevec G, Geer P, Santos RG, Lavoi TM, Giulianotti MA, Pinilla C, Appel JR, Houghten RA, Ericson MD, Haskell-Luevano C.. (2021) Discovery of Nanomolar Melanocortin-3 Receptor (MC3R)-Selective Small Molecule Pyrrolidine Bis-Cyclic Guanidine Agonist Compounds Via a High-Throughput "Unbiased" Screening Campaign., 64 (9.0): [PMID:33886285] [10.1021/acs.jmedchem.0c02041] |
